Pyke R E, Kraus M
Bronson Clinical Investigational Unit, Bronson Methodist Hospital, Kalamazoo, Mich.
J Clin Psychiatry. 1988 Feb;49(2):66-8.
Sixteen patients with panic attacks were treated with alprazolam at an anxiety clinic between March 1982 and April 1983. For all patients charts were reviewed for baseline data and treatment results at 1 and 6 months. Quantitated self-rating scales and the Clinical Global Impressions scale were used to assess progress. Alprazolam appeared effective for panic, agoraphobia, and depressive symptoms in 7 of 11 patients with either panic disorder or agoraphobia with panic attacks (DSM-III-defined diagnoses); side effects occurred in 4 of the 11 patients, were limited to oversedation, and resulted in no discontinuations of drug. However, alprazolam was ineffective in controlling panic, agoraphobia, and depression in 5 patients with panic attacks and secondary major depressive episode; for this group of patients, side effects were apparently paradoxical and required drug discontinuation in 3 of these 5 patients.
1982年3月至1983年4月期间,一家焦虑症诊所对16名惊恐发作患者使用阿普唑仑进行治疗。对所有患者的病历进行了回顾,以获取基线数据以及1个月和6个月时的治疗结果。使用定量自评量表和临床总体印象量表来评估进展情况。在11名患有惊恐障碍或伴有惊恐发作的广场恐惧症(根据《精神疾病诊断与统计手册》第三版定义的诊断)患者中,有7名患者的阿普唑仑对惊恐、广场恐惧症和抑郁症状有效;11名患者中有4名出现副作用,仅限于过度镇静,且没有导致停药。然而,阿普唑仑对5名伴有惊恐发作和继发性重度抑郁发作的患者控制惊恐、广场恐惧症和抑郁无效;对于这组患者,副作用显然是矛盾的,这5名患者中有3名需要停药。